Little Green Pharma (ASX:LGP) seals Scandinavian deal

Company News

by Michael Luu

Western Australia-based medical cannabis grower Little Green Pharma (ASX:LGP) has sealed a supply deal and stamp a foothold in the Scandinavian health and recreational pot market.

The $143 million company has officially become a supplier of medical cannabis oil and flowers to Danish distributor Balancial. The term of the agreement is 5 years, during which Little Green Pharma’s product prices will remain unchanged.

The deal marks the expansion of the ASX-listed pot grower’s European distribution network to Northern Europe from its existing Western European markets of Germany and France.

After listing on the ASX in February 2020, The company ignored pandemic challenges and went on to gain 145 per cent in share value in its first year as a listed company. FY21’s third quarter has also recorded a 24 per cent rise the Perth cannabis firm’s share price.

Shares in Little Green Pharma (ASX:LGP) are trading 3.3 per cent higher at 79 cents
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.